Literature DB >> 18429826

Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion.

Natsumi Tomita1, Toshiharu Matsumoto, Takuo Hayashi, Atsushi Arakawa, Hiroshi Sonoue, Yoshiaki Kajiyama, Masahiko Tsurumaru.   

Abstract

In squamous cell carcinoma (SCC) of the esophagus, D2-40 immunostaining has recently been used to detect lymphatic invasion, but invasion detected using D2-40 immunostaining for a predictor of nodal metastasis was controversial. Therefore, the usefulness of detecting lymphatic invasion by D2-40 immunostaining as a predictor of nodal metastasis was examined in superficial (mucosal and submucosal) SCC of the esophagus. A total of 115 superficial SCC of the esophagus were examined on immunohistochemistry using D2-40. It was found that lymphatic invasion demonstrated on D2-40 immunostaining was mainly detected in the lamina propria mucosa. Lymphatic invasion was found in 37 cases and the invasion detected in the entire tumor tissue was statistically correlated with nodal metastasis. Based on the lymphatic invasion according to D2-40 immunostaining, an algorithm was devised for the risk (low, intermediate and high) of nodal metastases in superficial SCC in the esophagus. In conclusion, the detection of lymphatic invasion on D2-40 immunostaining in tumor tissue is a strong predictor for nodal metastasis in superficial SCC of the esophagus. Lymphatic invasion was found mainly in the lamia propria mucosa, thus the devised algorithm is useful for determining the optimal treatment strategy after endoscopic mucosal resection for esophageal SCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18429826     DOI: 10.1111/j.1440-1827.2008.02224.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  11 in total

1.  Characteristics of Postoperative Recurrence in Lymph Node-Negative Superficial Esophageal Carcinoma.

Authors:  Yohei Ozawa; Takashi Kamei; Toru Nakano; Yusuke Taniyama; Shigehito Miyagi; Noriaki Ohuchi
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

2.  Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.

Authors:  Shengfei Wang; Yangle Huang; Juntao Xie; Lingdun Zhuge; Longlong Shao; Jiaqing Xiang; Yawei Zhang; Yihua Sun; Hong Hu; Sufeng Chen; Toni Lerut; James D Luketich; Jie Zhang; Haiquan Chen
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

Review 3.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

4.  Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.

Authors:  Yutaka Miyawaki; Hiroshi Sato; Naoto Fujiwara; Shuichiro Oya; Hirofumi Sugita; Yasumitsu Hirano; Tomohiko Yamane; Shinichi Sakuramoto; Kojun Okamoto; Shigeki Yamaguchi; Isamu Koyama
Journal:  Int J Clin Oncol       Date:  2019-12-23       Impact factor: 3.402

5.  Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx--value of conventional evaluation and additional immunohistochemical staining of D2-40.

Authors:  Hans-Ullrich Völker; Matthias Scheich; Isabell Nowack; Alexandra Metzger; Imme Haubitz; Bernhard Puppe; Rudolf Hagen; Hans-Konrad Müller-Hermelink; Christiane Völter
Journal:  World J Surg Oncol       Date:  2009-03-04       Impact factor: 2.754

6.  The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.

Authors:  Yichun Wang; Liyang Zhu; Wanli Xia; Liming Wu; Fan Wang
Journal:  World J Surg Oncol       Date:  2018-11-07       Impact factor: 2.754

7.  Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.

Authors:  Isao Hosono; Ryoji Miyahara; Kazuhiro Furukawa; Kohei Funasaka; Tsunaki Sawada; Keiko Maeda; Takeshi Yamamura; Takuya Ishikawa; Eizaburo Ohno; Masanao Nakamura; Hiroki Kawashima; Takio Yokoi; Tetsuya Tsukamoto; Yoshiki Hirooka; Mitsuhiro Fujishiro
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

8.  Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Kai-Yuan Jiang; Heng Huang; Wei-Yang Chen; Hao-Ji Yan; Zhen-Ting Wei; Xiao-Wen Wang; Hao-Xuan Li; Xiang-Yun Zheng; Dong Tian
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

9.  Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.

Authors:  Wei Ma; Kai Wang; Shaoqi Yang; Jianbo Wang; Bingxu Tan; Bing Bai; Nana Wang; Yibin Jia; Ming Jia; Yufeng Cheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma.

Authors:  Itaru Omoto; Masataka Matsumoto; Hiroshi Okumura; Yasuto Uchikado; Tetsuro Setoyama; Yoshiaki Kita; Tetsuhiro Owaki; Yuko Kijima; Hiroyuki Shinchi; Sumiya Ishigami; Shinichi Ueno; Shoji Natsugoe
Journal:  Oncol Lett       Date:  2014-01-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.